Natera (NTRA) Cash from Investing Activities (2014 - 2026)
Natera's (NTRA) quarterly Cash from Investing Activities came in at -$63.4 million in Q2 2026, down 165.43% on a YoY basis from $96.9 million in Q2 2025, and down 97.37% quarter-over-quarter from -$32.1 million in Q1 2026.
Analysis
Natera (NTRA) Cash from Investing Activities (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Cash from Investing Activities for 13 consecutive years, with -$63.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 165.43% year-over-year to -$63.4 million; the trailing twelve-month figure through Jun 2026 stood at -$187.1 million (down 1913.6% YoY), and the FY2025 full-year result was -$132.2 million, down 196.07% from the prior year.
- Cash from Investing Activities declined to -$63.4 million in Q2 2026 per NTRA's latest filing, from -$32.1 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $207.0 million in Q1 2022 and bottomed at -$71.6 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged $22.7 million across 5 years, with a median of $18.9 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities surged 771.17% in 2024, then slumped 543.93% in 2025.
- Over 5 years, Cash from Investing Activities stood at $21.9 million in 2022, then climbed by 10.17% to $24.1 million in 2023, then plunged by 146.05% to -$11.1 million in 2024, then plunged by 543.93% to -$71.6 million in 2025, then advanced by 11.4% to -$63.4 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$63.4 million, -$32.1 million, and -$71.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -63.43 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | -134.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -366.20 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 101.47 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -11.09 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -122.19 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | -43.30 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | -4.05 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -43.48 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -48.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63.43 Mn |
| Mar 31, 2026 | -32.14 Mn |
| Dec 31, 2025 | -71.59 Mn |
| Sep 30, 2025 | -19.91 Mn |
| Jun 30, 2025 | -23.90 Mn |
| Mar 31, 2025 | -16.82 Mn |
| Dec 31, 2024 | -11.12 Mn |
| Sep 30, 2024 | 42.54 Mn |
| Jun 30, 2024 | -32.05 Mn |
| Mar 31, 2024 | 138.26 Mn |
| Dec 31, 2023 | 24.15 Mn |
| Sep 30, 2023 | 81.29 Mn |
| Jun 30, 2023 | 47.19 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 21.92 Mn |
| Sep 30, 2022 | 66.60 Mn |
| Jun 30, 2022 | 34.79 Mn |
| Mar 31, 2022 | 207.03 Mn |
| Dec 31, 2021 | 79.50 Mn |
| Sep 30, 2021 | -431.41 Mn |